cyclohexanol has been researched along with Psychotic Disorders in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kyomen, HH; Whitfield, TH | 1 |
| Hegerl, U; Heinritz, W; Kopf, A; Strauss, M | 1 |
| Al-Najjar, T; Ali, BA; Nazer, LH; Shankar, G | 1 |
| Pfuhlmann, B; Reif, A | 1 |
| Hauser, P; Hisley, KC; Lefkowitz, DM; Marano, C; Obuchowski, A; Regenold, WT | 1 |
| Blashki, G; Keks, N | 1 |
| Sicot, R | 1 |
| Fernández, AS; López-García, P; Navarro, JS; Sádaba, B; Santos, PM; Vidal, JP | 1 |
| Kho, KH | 1 |
| Dagg, PK | 1 |
| Birkenhäger, TK; Moleman, P | 1 |
| Grube, M; Pfeffer, F | 1 |
2 review(s) available for cyclohexanol and Psychotic Disorders
| Article | Year |
|---|---|
[Is it advisable to combine electroconvulsive therapy (ECT) with psychotropics?].
Topics: Combined Modality Therapy; Cyclohexanols; Drug Interactions; Electroconvulsive Therapy; Humans; Lithium Compounds; Practice Guidelines as Topic; Psychotic Disorders; Psychotropic Drugs; Safety; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
[Two new antidepressants: mirtazapine and venlafaxine].
Topics: Adrenergic alpha-Antagonists; Benzamides; Cyclohexanols; Depressive Disorder; Drug Interactions; Female; Humans; Male; Mianserin; Mirtazapine; Moclobemide; Monoamine Oxidase Inhibitors; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Venlafaxine Hydrochloride | 1999 |
10 other study(ies) available for cyclohexanol and Psychotic Disorders
| Article | Year |
|---|---|
Psychosis in the elderly.
Topics: Aged, 80 and over; Alzheimer Disease; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Combined Modality Therapy; Comorbidity; Cyclohexanols; Delirium; Depressive Disorder, Major; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Humans; Memantine; Nootropic Agents; Piperazines; Psychotherapy; Psychotic Disorders; Quinolones; Risk Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
[Risperidone intoxication in a patient with a genetic predisposition as "poor [non]metabolizer"].
Topics: Adult; Antipsychotic Agents; Chromosomes, Human, Pair 22; Cyclohexanols; Cytochrome P-450 CYP2D6; Delusions; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Exons; Female; Genetic Carrier Screening; Humans; Inactivation, Metabolic; Introns; Metabolic Clearance Rate; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Fatal agranulocytosis associated with psychotropic medication use.
Topics: Adult; Agranulocytosis; Antidepressive Agents, Second-Generation; Antimanic Agents; Antipsychotic Agents; Blood Cell Count; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Fatal Outcome; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lamotrigine; Mianserin; Mirtazapine; Multiple Organ Failure; Neutropenia; Orbital Cellulitis; Psychotic Disorders; Psychotropic Drugs; Quetiapine Fumarate; Recombinant Proteins; Shock, Septic; Triazines; Venlafaxine Hydrochloride | 2012 |
Venlafaxine and reversible blepharoedema.
Topics: Adult; Cyclohexanols; Edema; Eye Diseases; Female; Humans; Hyponatremia; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2002 |
Relationship of white matter hyperintensities to cerebrospinal fluid glucose polyol pathway metabolites-a pilot study in treatment-resistant affective disorder patients.
Topics: Adult; Aged; Bipolar Disorder; Blood Glucose; Brain; Brain Diseases, Metabolic; Cyclohexanols; Depressive Disorder, Major; Diabetes Mellitus, Type 2; Drug Resistance; Female; Glucans; Humans; Image Enhancement; Image Processing, Computer-Assisted; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Pilot Projects; Psychotic Disorders; Psychotropic Drugs; Reference Values; Risk Factors; Sorbitol; Statistics as Topic; Venlafaxine Hydrochloride | 2005 |
The acutely psychotic patient--assessment and initial management.
Topics: Acute Disease; Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Cyclohexanols; Female; Humans; Male; Physicians, Family; Piperazines; Practice Guidelines as Topic; Psychotic Disorders; Quinolones; Referral and Consultation; Risk Assessment; Venlafaxine Hydrochloride | 2006 |
[Love, humor and psychosis in an atypical depression].
Topics: Antidepressive Agents; Antipsychotic Agents; Azabicyclo Compounds; Benzodiazepines; Clonazepam; Cyclohexanols; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Love; Olanzapine; Piperazines; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride; Wit and Humor as Topic | 2005 |
False positive phencyclidine results caused by venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Diagnosis, Differential; Drug Interactions; False Positive Reactions; Female; Humans; Middle Aged; Phencyclidine; Phencyclidine Abuse; Psychotic Disorders; Substance Abuse Detection; Venlafaxine Hydrochloride | 2007 |
Toxicity in venlafaxine overdose.
Topics: Adult; Antidepressive Agents, Second-Generation; Coma; Cyclohexanols; Dose-Response Relationship, Drug; Drug Overdose; Humans; Male; Neurologic Examination; Psychotic Disorders; Venlafaxine Hydrochloride | 1997 |
An organic psychosis due to a venlafaxine-propafenone interaction.
Topics: Aged; Bipolar Disorder; Cyclohexanols; Drug Interactions; Female; Humans; Propafenone; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2001 |